Skip to main content
. Author manuscript; available in PMC: 2024 Mar 19.
Published in final edited form as: Dig Dis Sci. 2020 May 24;66(4):1240–1248. doi: 10.1007/s10620-020-06341-z

Table 3:

Outcomes

Variables n (%)

Surgery (n=56)
 Gastrectomy (subtotal) 22 (39.3)
 Gastrectomy (total) 13 (23.2)
 No surgery 21 (37.5)
Neoadjuvant chemotherapy (n=51)
 Yes 5 (9.8)
 No 46 (90.2)
Chemotherapy (n=51)
 Yes (palliative and curative) 39 (76.5)
 No 12 (23.5)
Survival
 Median survival (months) 12.6
 3 months 44/55 (80.0)
 6 months 33/53 (62.3)
 12 months 27/51 (52.9)
 24 months 10/45 (22.2)
 60 months 6/42 (14.3)